Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Leap Therapeutics (LPTX) Earnings Date, Estimates & Call Transcripts

Leap Therapeutics logo

Leap Therapeutics Earnings Summary

Leap Therapeutics announced Q3 2025 earnings on November 12, 2025, reporting an EPS of -$0.08. Leap Therapeutics currently has a trailing EPS of -$1.22

Q3 2025 Earnings Resources

Get Leap Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Leap Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Leap Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2025Q3 2025--$0.08--$0.08--

Data powered by Fiscal.ai.


This page (NASDAQ:LPTX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners